During study period, 22 percent with GBS had confirmed or probable SARS-CoV-2 infection; patients had uniform neurologic features
Risk for Bell Palsy Up 42 Days After First Dose of CoronaVac
Hong Kong study shows small increased risk after Sinovac Biotech vaccine, but no significantly increased risk after BNT162b2 vaccine
AAO-HNS Issues Guidance for Bell’s Palsy Treatment During COVID-19
Corticosteroid therapy and/or antiherpes viral therapy recommended for patients developing Bell’s palsy after vaccination